yttrium radioisotopes has been researched along with Bile Duct Cancer in 68 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (4.41) | 29.6817 |
2010's | 36 (52.94) | 24.3611 |
2020's | 29 (42.65) | 2.80 |
Authors | Studies |
---|---|
Bailly, C; Becker, S; Blanc, JF; Boucher, E; Bouvier, A; Chevallier, P; de Baere, T; Edeline, J; Garin, E; Goupil, J; Guiu, B; Manfredi, S; Mariano-Goulart, D; Mastier, C; Patel, B; Pinaquy, JB; Regnault, H; Rode, A; Sefrioui, D; Sengel, C; Somma, C; Tordo, J; Vibert, E; Vicaut, E | 1 |
Butani, D; Cantos, A; Gupta, A; Kallas, J; Porter, M; Schartz, DA; Schartz, E | 1 |
Benson, AB; Bentrem, DJ; Caicedo-Ramirez, JC; Desai, K; Gabr, A; Gordon, AC; Gupta, AN; Hohlastos, ES; Kalyan, A; Kircher, SM; Kulik, L; Lewandowski, RJ; Mahalingam, D; Merkow, RP; Mulcahy, MF; Riaz, A; Salem, R; Sato, KT; Thornburg, B; Yang, AD | 1 |
Abdelsalam, ME; Habibollahi, P; Hosseini Shabanan, S; Mahvash, A; Nezami, N; Odisio, BC; Sheth, RA | 1 |
Boudjema, K; Bourien, H; Campillo-Gimenez, B; Edeline, J; Garin, E; Rolland, Y; Trochet, M | 1 |
Brown, DB; Collins, ZS; Du, L; Gandhi, RT; Grilli, CJ; Kennedy, AS; Kokabi, N; Kouri, BE; Lee, JS; Matsuoka, L; Robinson, TJ; Sze, DY; Wang, EA | 1 |
Ahmed, O; Baker, T; Fung, J; Hwang, G; Liao, CY; Patel, M; Pillai, A; Yu, Q | 1 |
Abou-Alfa, GK; Alexander, ES; Erinjeri, JP; Jarnagin, WR; Karimi, A; Marinelli, B; Moussa, AM; Sofocleous, CT; Sotirchos, VS; Yarmohammadi, H; Zhao, K; Ziv, E | 1 |
Cuneo, KC; Herr, DJ | 1 |
Choi, J; El-Haddad, G; Frakes, JM; Gyano, M; Hoffe, SE; Kim, RD; Kis, B; Mhaskar, R; Shridhar, R | 1 |
Ahmed, O; Baker, T; Kwak, D; Liao, CY; Little, K; Marshall, E; Patel, M; Pillai, A; Ungchusri, E; Van Ha, T; Wang, Y; Yu, Q; Zangan, S | 1 |
Bagni, O; Cianni, R; Di Costanzo, GG; Filippi, L; Marino Marsilia, G; Pelle, G; Saltarelli, A; Schillaci, O; Tortora, R | 1 |
Affonso, BB; Carvalho, VO; Falsarella, PM; Ferraz-Neto, BH; Galastri, FL; Garcia, RG; Motta-Leal-Filho, JMD; Nasser, F; Rezende, MB; Valle, LGM | 1 |
Duzenli, T; Koseoglu, H | 1 |
Bozbulut, UB; Bozkurt, M; Bozkurt, MF; Çil, B; Eldem, G; Kılıçkap, S; Lay Ergün, E; Peynircioğlu, B; Volkan-Salanci, B | 1 |
Baltacioglu, F; Calik, A; Cobanoglu, U; Kucukaslan, H; Oguz, S; Ones, T; Topaloglu, S | 1 |
Bargellini, I; Boni, G; Cappelli, A; Cappelli, F; Cioni, R; Golfieri, R; Lorenzoni, G; Masi, G; Mosconi, C; Paladini, A; Pizzi, G; Sciuto, R; Vallati, GE; Vivaldi, C | 1 |
Ahmed, M; Ali, A; Bullock, AJ; Curry, MP; Faintuch, S; Ljuboja, D; Morrow, MK; Nasser, IA; Sarwar, A; Shenoy-Bhangle, AS; Weinstein, JL | 1 |
Ascanio, S; Cappelli, A; Cucchetti, A; Galaverni, MC; Golfieri, R; Gramenzi, A; Modestino, F; Mosconi, C; Pettinari, I; Pettinato, C; Renzulli, M | 1 |
Abdelrazek Mohammed, MA; Chan, LS; Louie, JD; Poultsides, GA; Sze, DY; Wang, DS | 1 |
Binnenhei, M; Justinger, M; Reimer, P; Schön, MR; Tatsch, K; Virarkar, MK | 1 |
Assifi, MM; Chung, C; Chung, MH; Doherty, MG; Shaker, TM; Varma, MK; Wolf, AM | 1 |
Camacho, JC; Kim, HS; Kokabi, N; Nezami, N; Schuster, DM; Xing, M | 1 |
D'Hondt, M; Dedeurwaerdere, F; Smet, B; Willems, E | 1 |
Bagni, O; Cianni, R; Di Costanzo, GG; Filippi, L; Pelle, G; Schillaci, O; Tortora, R | 1 |
Bodei, L; Chiesa, C; Cremonesi, M; Flamen, P; Garin, E; Gnesin, S; Herrmann, K; Konijnenberg, M; Kracmerova, T; Lam, M; Luster, M; Weber, M | 1 |
Helmberger, T; Pereira, PL | 1 |
Arora, M; Devcic, Z; Frey, G; Lewis, AR; McKinney, JM; Montazeri, SA; Padula, CA; Paz-Fumagalli, R; Ritchie, C; Toskich, BB | 1 |
Auer, TA; Demircioglu, A; Dertnig, T; Gebauer, B; Kasper, S; Kloeckner, R; Miederer, M; Müller, L; Radunz, S; Santos, DPD; Schaarschmidt, BM; Steinle, V; Theysohn, J; Weber, M | 1 |
Fidelman, N; Heller, M; Lam, A; Lokken, RP; Wu, X | 1 |
Blesl, A; Brcic, I; Fickert, P; Jaschke, W; Öfner, D; Plank, J | 1 |
Akinwande, O; Gibby, W; Kim, SK; Lancia, S; Malone, CD; Ramaswamy, RS; Tsai, R | 1 |
Bell, JK; Borgmann, AJ; Braat, AJAT; Brown, DB; Buettner, S; Hagendoorn, J; IJzermans, JNM; Kappadath, SC; Koerkamp, BG; Lam, MGEH; Lamarca, A; Mahvash, A; Margonis, GA; Sze, DY; Taylor, KB; Valle, JW; Weiss, MJ | 1 |
Brandi, N; Cappelli, A; Cucchetti, A; Golfieri, R; Modestino, F; Mosconi, C; Solaini, L; Vara, G | 1 |
Bercu, Z; Brandon, D; Cheng, B; Galt, J; Kokabi, N; Majdalany, B; Schuster, DM; Sethi, I; Villalobos, A; Wagstaff, W | 1 |
Edeline, J; Groot Koerkamp, B; Guiu, B; Hubner, RA; Jacobs, T; Johnson, P; Lamarca, A; McNamara, MG; Palmer, D; Valle, JW | 1 |
Anaya, DA; Arslan, B; Biebel, B; Chen, DT; Chen, Y; Choi, J; El-Haddad, G; Frakes, JM; Gangi, A; Hatfield, N; Hoffe, SE; Kim, RD; Kis, B; Malafa, M; Parikh, N; Shah, J; Shridhar, R; Smith, J; Springett, GM; Sweeney, J | 1 |
Benito, A; Chopitea, A; Iñarrairaegui, M; Jaureguizar, JIB; Páramo, M; Rodríguez-Fraile, M; Sancho, L; Sangro, B | 1 |
Ghodadra, A; Kim, HS; Xing, M; Zhang, D | 1 |
Bell, JK; Carolan-Rees, G; Crellin, A; Dale, M; Manas, DM; Patrick, HE; See, TC; Sharma, RA; Slevin, NJ; White, J | 1 |
Chen, YF; Gaba, RC; Guzman, G; Huang, YH; Lokken, RP; Park, BV | 1 |
Baker, T; Benson, AB; Gupta, R; Lewandowski, RJ; Memon, K; Mouli, S; Mulcahy, MF; Ryu, RK; Salem, R | 1 |
Gates, VL; Lewandowski, RJ; Memon, K; Minocha, J; Omary, R; Riaz, A; Ryu, RK; Salem, R; Sato, KT | 1 |
Camacho, JC; El-Rayes, B; Kim, HS; Kokabi, N; Prajapati, HJ; Xing, M | 1 |
Chiesa, C; Maccauro, M; Mazzaferro, V; Spreafico, C | 1 |
Justinger, C; Kollmar, O; Schuld, J; Seidel, R; Sperling, J; Ziemann, C | 1 |
Camacho, JC; Kim, HS; Kokabi, N; Schuster, DM; Xing, M | 1 |
Boehm, LM; Gamblin, TC; Jayakrishnan, TT; Johnston, FM; Miura, JT; Turaga, KK; Zacharias, AJ | 1 |
Bagni, O; Cianni, R; Filippi, L; Pelle, G; Scopinaro, F | 1 |
Al-Adra, DP; Axford, SJ; Gill, RS; Kneteman, N; Liau, SS; Shi, X | 1 |
Boucher, E; Boudjema, K; Edeline, J; Garin, E; Levi Sandri, GB; Meunier, B; Rayar, M; Sulpice, L | 1 |
Ricke, J; Seidensticker, M; Seidensticker, R | 1 |
Camacho, JC; Kim, HS; Kokabi, N; Lahti, S; Schuster, DM; Xing, M | 1 |
Bilgic, S; Ibis, E; Kucuk, ON; Soydal, C | 1 |
Baker, E; Halpin, LE; Hessey, JA; Iannitti, DA; Martinie, JB; McBrier, NM; Ross, S; Simo, KA; Swan, RZ | 1 |
Ascanio, S; Brandi, G; Cappelli, A; Cucchetti, A; Golfieri, R; Gramenzi, A; Monari, F; Mosconi, C; Pettinato, C; Renzulli, M; Trevisani, F | 1 |
Beuzit, L; Boudjema, K; Brun, V; Edeline, J; Gandon, Y; Garin, E; Guillygomarc'h, A; Rolland, Y; Ronot, M | 1 |
Boudjema, K; Camus, C; Houssel-Debry, P; Levi Sandri, GB; Rayar, M; Sulpice, L | 1 |
Benson, A; Ibrahim, SM; Lewandowski, RJ; Masterson, EJ; Mulcahy, MF; Newman, SB; Omary, RA; Ryu, RK; Salem, R; Sato, KT | 1 |
Abecassis, MM; Baker, TB; Gaba, RC; Gates, V; Ibrahim, SM; Kulik, LM; Lewandowski, RJ; Mulcahy, MF; Omary, RA; Riaz, A; Ryu, RK; Salem, R; Sato, KT | 1 |
Bester, L; Chu, FC; Chua, TC; Morris, DL; Saxena, A | 1 |
Coldwell, D; Kennedy, A; Salem, R; Sangro, B; Wasan, H | 1 |
Bartenstein, P; Bruns, CJ; Hacker, M; Haug, AR; Heinemann, V; Hoffmann, R; Jakobs, T | 1 |
Bamberg, F; Dürr, EM; Haug, A; Helmberger, TK; Hoffmann, RT; Jakobs, TF; Kolligs, FT; Paprottka, PM; Rauch, B; Reiser, MF; Schön, A; Trumm, CT | 1 |
El-Rayes, B; Kauh, JS; Kim, HS; Kooby, DA; Piduru, SM; Rafi, S; Sarmiento, JM | 1 |
Bernhardt, P; Gjertsson, P; Henrikson, O; Högberg, J; Hultborn, R; Rizell, M; Svensson, J | 1 |
Benito, A; Bilbao, JI; Chopitea, A; D'Avola, D; Dominguez, I; Gil-Alzugaray, B; Herrero, JI; Iñarrairaegui, M; Prieto, J; Quiroga, J; Rodriguez, J; Rodriguez-Fraile, M; Sangro, B | 1 |
Barakat, O; Hoef, J; Ozaki, CF; Patrick Wood, R | 1 |
11 review(s) available for yttrium radioisotopes and Bile Duct Cancer
Article | Year |
---|---|
Transarterial Yttrium-90 Radioembolization for Unresectable Intrahepatic Cholangiocarcinoma: A Systematic Review and Meta-Analysis.
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; CA-19-9 Antigen; Cholangiocarcinoma; Embolization, Therapeutic; Humans; Liver Neoplasms; Treatment Outcome; Yttrium Radioisotopes | 2022 |
Selective Internal Radiation Therapy with Yttrium-90 for Intrahepatic Cholangiocarcinoma: A Systematic Review on Post-Treatment Dosimetry and Concomitant Chemotherapy.
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Chemoradiotherapy; Cholangiocarcinoma; Humans; Yttrium Radioisotopes | 2022 |
Advances in Radiation Therapy for Primary Liver Cancer.
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Radiosurgery; Yttrium Radioisotopes | 2023 |
[Transarterial radioembolization of hepatocellular carcinoma and intrahepatic cholangiocarcinoma].
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Cholangiocarcinoma; Humans; Liver Neoplasms; Yttrium Radioisotopes | 2022 |
Transarterial Chemoembolization and Radioembolization for Unresectable Intrahepatic Cholangiocarcinoma-a Systemic Review and Meta-Analysis.
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Chemoembolization, Therapeutic; Cholangiocarcinoma; Humans; Yttrium Radioisotopes | 2021 |
Locoregional therapies in patients with intrahepatic cholangiocarcinoma: A systematic review and pooled analysis.
Topics: Ablation Techniques; Antineoplastic Agents; Bile Duct Neoplasms; Chemoembolization, Therapeutic; Cholangiocarcinoma; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Cohort Studies; Embolization, Therapeutic; Hepatic Artery; Humans; Infusions, Intra-Arterial; Randomized Controlled Trials as Topic; Yttrium Radioisotopes | 2021 |
Comparative effectiveness of hepatic artery based therapies for unresectable intrahepatic cholangiocarcinoma.
Topics: Antineoplastic Agents; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Chemoembolization, Therapeutic; Cholangiocarcinoma; Drug Carriers; Embolization, Therapeutic; Hepatic Artery; Humans; Infusions, Intra-Arterial; Radiopharmaceuticals; Yttrium Radioisotopes | 2015 |
Treatment of unresectable intrahepatic cholangiocarcinoma with yttrium-90 radioembolization: a systematic review and pooled analysis.
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Disease-Free Survival; Embolization, Therapeutic; Humans; Microspheres; Radiopharmaceuticals; Treatment Outcome; Yttrium Radioisotopes | 2015 |
Integration of chemoembolization and radioembolization into multimodal treatment of cholangiocarcinoma.
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Combined Modality Therapy; Embolization, Therapeutic; Humans; Radiopharmaceuticals; Treatment Outcome; Yttrium Radioisotopes | 2015 |
Multimodality treatment of intrahepatic cholangiocarcinoma: A review.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Catheter Ablation; Cholangiocarcinoma; Combined Modality Therapy; Embolization, Therapeutic; Humans; Immunotherapy; Prognosis; Proton Therapy; Radiosurgery; United States; Yttrium Radioisotopes | 2016 |
Radioembolization in the treatment of unresectable liver tumors: experience across a range of primary cancers.
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Breast Neoplasms; Carcinoma, Hepatocellular; Cholangiocarcinoma; Colorectal Neoplasms; Embolization, Therapeutic; Glass; Hepatectomy; Humans; Liver Neoplasms; Lung Neoplasms; Melanoma; Microspheres; Resins, Synthetic; Treatment Outcome; Uveal Neoplasms; Yttrium Radioisotopes | 2012 |
3 trial(s) available for yttrium radioisotopes and Bile Duct Cancer
Article | Year |
---|---|
Evaluating the Effectiveness of Yttrium-90 Glass Microspheres in the Treatment of Hepatocellular Carcinoma, Intrahepatic Cholangiocarcinoma, and Metastatic Colorectal Cancer in Practice: Protocol for the Prospective PROACTIF Phase IV Registry Study in Fra
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hepatocellular; Cholangiocarcinoma; Clinical Trials, Phase IV as Topic; Colorectal Neoplasms; Embolization, Therapeutic; Humans; Liver Neoplasms; Microspheres; Prospective Studies; Quality of Life; Registries; Treatment Outcome; Yttrium Radioisotopes | 2022 |
Sustained safety and efficacy of extended-shelf-life (90)Y glass microspheres: long-term follow-up in a 134-patient cohort.
Topics: Aged; Bile Duct Neoplasms; Carcinoma, Hepatocellular; Cholangiocarcinoma; Drug Stability; Female; Follow-Up Studies; Glass; Humans; Liver Neoplasms; Male; Microspheres; Middle Aged; Radiopharmaceuticals; Yttrium Radioisotopes | 2014 |
Treatment of unresectable cholangiocarcinoma using yttrium-90 microspheres: results from a pilot study.
Topics: Adult; Aged; Aged, 80 and over; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Brachytherapy; Cholangiocarcinoma; Female; Humans; Kaplan-Meier Estimate; Male; Microspheres; Middle Aged; Pilot Projects; Positron-Emission Tomography; Tomography, X-Ray Computed; Yttrium Radioisotopes | 2008 |
54 other study(ies) available for yttrium radioisotopes and Bile Duct Cancer
Article | Year |
---|---|
Yttrium-90 Radioembolization of Unresectable Intrahepatic Cholangiocarcinoma: Long-Term Follow-up for a 136-Patient Cohort.
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Cohort Studies; Embolization, Therapeutic; Follow-Up Studies; Humans; Liver Neoplasms; Retrospective Studies; Treatment Outcome; Yttrium Radioisotopes | 2022 |
Selective Internal Radiation Therapy (Yttrium-90 Glass Microspheres) Combined with Capecitabine in the Neoadjuvant Setting of Operable Intrahepatic CHOlangiocarcinoma: The SIROCHO Trial Design.
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Capecitabine; Cholangiocarcinoma; Humans; Radiopharmaceuticals | 2023 |
Survival and Toxicities after Yttrium-90 Transarterial Radioembolization of Cholangiocarcinoma in the RESiN Registry.
Topics: Aged; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Embolization, Therapeutic; Humans; Liver Neoplasms; Male; Retrospective Studies; Treatment Outcome; Yttrium Radioisotopes | 2023 |
Yttrium-90 Radioembolization and Concomitant Systemic Gemcitabine, Cisplatin, and Capecitabine as the First-Line Therapy for Locally Advanced Intrahepatic Cholangiocarcinoma.
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Capecitabine; Cholangiocarcinoma; Cisplatin; Gemcitabine; Humans; Retrospective Studies; Treatment Outcome; Yttrium Radioisotopes | 2023 |
Factors affecting outcomes of Yttrium-90 radioembolization in heavily pretreated patients with intrahepatic cholangiocarcinoma.
Topics: Aged; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Embolization, Therapeutic; Female; Humans; Male | 2023 |
Radioembolization with Yttrium-90 Glass Microspheres as a First-Line Treatment for Unresectable Intrahepatic Cholangiocarcinoma-A Prospective Feasibility Study.
Topics: Aged; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Embolization, Therapeutic; Feasibility Studies; Female; Humans; Liver Neoplasms; Microspheres; Prospective Studies; Treatment Outcome; Yttrium Radioisotopes | 2023 |
Segmental Yttrium-90 Radioembolization Using Glass Microspheres Greater than 400 Gray for the Treatment of Intrahepatic Cholangiocarcinoma: A Preliminary Experience.
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hepatocellular; Cholangiocarcinoma; Embolization, Therapeutic; Humans; Liver Neoplasms; Microspheres; Necrosis; Retrospective Studies; Treatment Outcome; Yttrium Radioisotopes | 2023 |
Prognostic value of neutrophil-to-lymphocyte ratio and its correlation with fluorine-18-fluorodeoxyglucose metabolic parameters in intrahepatic cholangiocarcinoma submitted to 90Y-radioembolization.
Topics: Adult; Aged; Bile Duct Neoplasms; Cell Count; Cholangiocarcinoma; Embolization, Therapeutic; Female; Fluorodeoxyglucose F18; Humans; Lymphocytes; Male; Middle Aged; Neutrophils; Positron Emission Tomography Computed Tomography; Prognosis; Yttrium Radioisotopes | 2020 |
Transarterial radioembolization for liver tumors as neoadjuvant therapy: three case reports.
Topics: Adult; Aged; Bile Duct Neoplasms; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Cholangiocarcinoma; Disease Progression; Female; Humans; Liver Neoplasms; Male; Middle Aged; Neoadjuvant Therapy; Treatment Outcome; Yttrium Radioisotopes | 2020 |
Predictive role of neutrophil to lymphocyte ratio in patients with intrahepatic cholangiocarcinoma submitted to treatment of 90Y-microspheres.
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Fluorodeoxyglucose F18; Humans; Lymphocytes; Microspheres; Neutrophils; Prognosis; Yttrium Radioisotopes | 2020 |
Factors affecting the response to Y-90 microsphere therapy in the cholangiocarcinoma patients.
Topics: Adult; Aged; Bile Duct Neoplasms; Cholangiocarcinoma; Female; Humans; Magnetic Resonance Imaging; Male; Microspheres; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Response Evaluation Criteria in Solid Tumors; Retrospective Studies; Tomography, Emission-Computed, Single-Photon; Tumor Burden; Yttrium Radioisotopes | 2021 |
Is it Possible to Increase Survival of Patients with Intrahepatic Cholangiocarcinoma? A Case Report.
Topics: Aged; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Chemoradiotherapy, Adjuvant; Cholangiocarcinoma; Cholecystectomy; Fatal Outcome; Fluorouracil; Hepatectomy; Humans; Magnetic Resonance Imaging; Male; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Reoperation; Time Factors; Yttrium Radioisotopes | 2021 |
Yttrium-90 Radioembolization in Unresectable Intrahepatic Cholangiocarcinoma: Results of a Multicenter Retrospective Study.
Topics: Aged; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Embolization, Therapeutic; Female; Humans; Male; Middle Aged; Neoplasm Staging; Retrospective Studies; Treatment Outcome; Yttrium Radioisotopes | 2020 |
Neoadjuvant Yttrium-90 Transarterial Radioembolization with Resin Microspheres Prescribed Using the Medical Internal Radiation Dose Model for Intrahepatic Cholangiocarcinoma.
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Humans; Liver Neoplasms; Male; Microspheres; Neoadjuvant Therapy; Radiation Dosage; Retrospective Studies; Yttrium Radioisotopes | 2021 |
Yttrium-90 microsphere radioembolization in unresectable intrahepatic cholangiocarcinoma.
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Brachytherapy; Cholangiocarcinoma; Embolization, Therapeutic; Humans; Microspheres; Patient Selection; Preoperative Care; Radiometry; Radiopharmaceuticals; Randomized Controlled Trials as Topic; Response Evaluation Criteria in Solid Tumors; Yttrium Radioisotopes | 2017 |
Yttrium-90 Radioembolization for Unresectable Combined Hepatocellular-Cholangiocarcinoma.
Topics: Aged; Bile Duct Neoplasms; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Chemoradiotherapy; Cholangiocarcinoma; Female; Humans; Liver Neoplasms; Male; Middle Aged; Retrospective Studies; Yttrium Radioisotopes | 2017 |
Prognostic Factors in Overall Survival of Patients with Unresectable Intrahepatic Cholangiocarcinoma Treated by Means of Yttrium-90 Radioembolization: Results in Therapy-Naïve Patients.
Topics: Aged; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Brachytherapy; Cholangiocarcinoma; Female; Humans; Male; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies; Survival Analysis; Treatment Outcome; Yttrium Radioisotopes | 2018 |
Is there a role for Ytrrium-90 in the treatment of unresectable and metastatic intrahepatic cholangiocarcinoma?
Topics: Adult; Aged; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Linear Models; Male; Middle Aged; Neoplasm Metastasis; Radiopharmaceuticals; Retrospective Studies; Treatment Outcome; Yttrium Radioisotopes | 2018 |
Topics: Bile Duct Neoplasms; Biological Transport; Cholangiocarcinoma; Embolization, Therapeutic; Female; Glass; Humans; Male; Microspheres; Middle Aged; Radiometry; Resins, Synthetic; Retrospective Studies; Single Photon Emission Computed Tomography Computed Tomography; Technetium Tc 99m Aggregated Albumin; Yttrium Radioisotopes | 2018 |
Foreign body granuloma reaction following SIRT mimicking peritoneal metastases: a word of caution.
Topics: Bile Duct Neoplasms; Brachytherapy; Cholangiocarcinoma; Diagnosis, Differential; Female; Granuloma, Foreign-Body; Humans; Microspheres; Middle Aged; Peritoneal Neoplasms; Yttrium Radioisotopes | 2020 |
Repeated Treatment with
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Embolization, Therapeutic; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Liver; Male; Microspheres; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Radiotherapy, Adjuvant; Retreatment; Retrospective Studies; Treatment Outcome; Yttrium Radioisotopes | 2019 |
EANM procedure guideline for the treatment of liver cancer and liver metastases with intra-arterial radioactive compounds.
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hepatocellular; Embolization, Therapeutic; Humans; Liver Neoplasms; Microspheres; Yttrium Radioisotopes | 2022 |
Radiation Segmentectomy for the Treatment of Primary Hepatic Malignancies of the Caudate Lobe: A Case Series.
Topics: Aged; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hepatocellular; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Male; Microspheres; Pneumonectomy; Radiopharmaceuticals; Retrospective Studies; Treatment Outcome; Yttrium Radioisotopes | 2022 |
Real-Life Experience in the Treatment of Intrahepatic Cholangiocarcinoma by
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Male; Retrospective Studies; Treatment Outcome; Yttrium Radioisotopes | 2023 |
Socioeconomic and Survival Analysis of Radioembolization in Patients with Intrahepatic Cholangiocarcinoma: A Propensity Score-Adjusted Study.
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hepatocellular; Cholangiocarcinoma; Humans; Liver Neoplasms; Male; Propensity Score; Retrospective Studies; Survival Analysis; Yttrium Radioisotopes | 2023 |
Chronic gastric ulcer disease complicating selective internal radiation therapy (SIRT) in a patient with cholangiocellular carcinoma.
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Female; Hepatic Artery; Humans; Microspheres; Middle Aged; Radiation Injuries; Stomach Ulcer; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Yttrium Radioisotopes | 2019 |
Outcomes of Yttrium-90 Radioembolization for Unresectable Combined Biphenotypic Hepatocellular-Cholangiocarcinoma.
Topics: Aged; Bile Duct Neoplasms; CA-19-9 Antigen; Carcinoma, Hepatocellular; Cholangiocarcinoma; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Neoplasms, Complex and Mixed; Phenotype; Radiopharmaceuticals; Retrospective Studies; Time Factors; Treatment Outcome; Yttrium Radioisotopes | 2020 |
Yttrium-90 Radioembolization in Intrahepatic Cholangiocarcinoma: A Multicenter Retrospective Analysis.
Topics: Bile Duct Neoplasms; Cholangiocarcinoma; Embolization, Therapeutic; Female; Humans; Male; Radiopharmaceuticals; Retrospective Studies; Time Factors; Treatment Outcome; Yttrium Radioisotopes | 2020 |
Determination of Tumor Dose Response Thresholds in Patients with Chemorefractory Intrahepatic Cholangiocarcinoma Treated with Resin and Glass-based Y90 Radioembolization.
Topics: Aged; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Embolization, Therapeutic; Female; Glass; Humans; Kaplan-Meier Estimate; Male; Microspheres; Retrospective Studies; Single Photon Emission Computed Tomography Computed Tomography; Survival Analysis; Treatment Outcome; Yttrium Radioisotopes | 2021 |
Intrahepatic Cholangiocarcinoma Treated with Transarterial Yttrium-90 Glass Microsphere Radioembolization: Results of a Single Institution Retrospective Study.
Topics: Aged; Aged, 80 and over; Aspartate Aminotransferases; Bile Duct Neoplasms; Bilirubin; CA-19-9 Antigen; Cholangiocarcinoma; Embolization, Therapeutic; Female; Glass; Humans; International Normalized Ratio; Kaplan-Meier Estimate; Male; Microspheres; Middle Aged; Multivariate Analysis; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Serum Albumin, Human; Time Factors; Treatment Outcome; Yttrium Radioisotopes | 2018 |
Segmental Pneumonitis after Radioembolization.
Topics: Aged; Bile Duct Neoplasms; Cholangiocarcinoma; Computed Tomography Angiography; Disease Progression; Embolization, Therapeutic; Fatal Outcome; Female; Humans; Positron Emission Tomography Computed Tomography; Radiation Pneumonitis; Radiopharmaceuticals; Yttrium Radioisotopes | 2018 |
Yttrium-90 Radioembolization Is Cost Effective in Intrahepatic Cholangiocarcinoma: A SEER Medicare Population Study.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Bile Duct Neoplasms; Chemoradiotherapy; Cholangiocarcinoma; Cost-Benefit Analysis; Databases, Factual; Drug Costs; Embolization, Therapeutic; Female; Health Care Costs; Humans; Male; Medicare; Radiopharmaceuticals; Retrospective Studies; SEER Program; Time Factors; Treatment Outcome; United States; Yttrium Radioisotopes | 2019 |
Yttrium-90 Transarterial Radioembolization for Chemotherapy-Refractory Intrahepatic Cholangiocarcinoma: A Prospective, Observational Study.
Topics: Aged; Bile Duct Neoplasms; Cholangiocarcinoma; Disease Progression; Drug Resistance, Neoplasm; Embolization, Therapeutic; England; Female; Humans; Male; Middle Aged; Progression-Free Survival; Prospective Studies; Radiopharmaceuticals; Risk Factors; Time Factors; Yttrium Radioisotopes | 2019 |
Locoregional Therapy of Hepatocellular-Cholangiocarcinoma versus Hepatocellular Carcinoma: A Propensity Score-Matched Study.
Topics: Aged; Bile Duct Neoplasms; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Cholangiocarcinoma; Combined Modality Therapy; Disease Progression; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Progression-Free Survival; Radiofrequency Ablation; Radiopharmaceuticals; Retrospective Studies; Risk Assessment; Risk Factors; Time Factors; Yttrium Radioisotopes | 2019 |
Yttrium-90 radioembolization for intrahepatic cholangiocarcinoma: safety, response, and survival analysis.
Topics: Aged; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Disease Progression; Embolization, Therapeutic; Female; Hepatectomy; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Male; Middle Aged; Multivariate Analysis; Neoadjuvant Therapy; Proportional Hazards Models; Radiopharmaceuticals; Radiotherapy, Adjuvant; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome; Yttrium Radioisotopes | 2013 |
Modified response evaluation criteria in solid tumors and European Association for The Study of the Liver criteria using delayed-phase imaging at an early time point predict survival in patients with unresectable intrahepatic cholangiocarcinoma following
Topics: Adult; Aged; Aged, 80 and over; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Embolization, Therapeutic; Female; Humans; Kaplan-Meier Estimate; Magnetic Resonance Imaging; Male; Middle Aged; Multidetector Computed Tomography; Predictive Value of Tests; Proportional Hazards Models; Prospective Studies; Radiopharmaceuticals; Risk Factors; Time Factors; Treatment Outcome; Tumor Burden; Yttrium Radioisotopes | 2014 |
The dosimetric importance of the number of 90Y microspheres in liver transarterial radioembolization (TARE).
Topics: Bile Duct Neoplasms; Carcinoma, Hepatocellular; Cholangiocarcinoma; Female; Humans; Liver Neoplasms; Male; Microspheres; Radiopharmaceuticals; Yttrium Radioisotopes | 2014 |
Intrahepatic cholangiocarcinoma in a transplant liver--selective internal radiation therapy followed by right hemihepatectomy: report of a case.
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Brachytherapy; Carcinoma, Hepatocellular; Cholangiocarcinoma; Combined Modality Therapy; Embolization, Therapeutic; Hepatectomy; Hepatolenticular Degeneration; Humans; Liver Neoplasms; Liver Transplantation; Microspheres; Middle Aged; Prognosis; Yttrium Radioisotopes | 2014 |
PET response criteria for solid tumors predict survival at three months after intra-arterial resin-based 90Yttrium radioembolization therapy for unresectable intrahepatic cholangiocarcinoma.
Topics: Adult; Aged; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Embolization, Therapeutic; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Survival Analysis; Tomography, X-Ray Computed; Yttrium Radioisotopes | 2014 |
Change in total lesion glycolysis and clinical outcome after (90)Y radioembolization in intrahepatic cholangiocarcinoma.
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Embolization, Therapeutic; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2015 |
Intra-arterial yttrium-90 radioembolization combined with systemic chemotherapy is a promising method for downstaging unresectable huge intrahepatic cholangiocarcinoma to surgical treatment.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Cholangiocarcinoma; Combined Modality Therapy; Embolization, Therapeutic; Female; Follow-Up Studies; Hepatectomy; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Yttrium Radioisotopes | 2015 |
90Y Radioembolization Lung Shunt Fraction in Primary and Metastatic Liver Cancer as a Biomarker for Survival.
Topics: Aged; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Biomarkers; Cholangiocarcinoma; Colorectal Neoplasms; Embolization, Therapeutic; Female; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Lung; Lung Neoplasms; Male; Middle Aged; Neuroendocrine Tumors; Pulmonary Ventilation; Radionuclide Imaging; Retrospective Studies; Technetium Tc 99m Aggregated Albumin; Tumor Burden; Yttrium Radioisotopes | 2016 |
Radioembolization with (90)Y resin microspheres for intrahepatic cholangiocellular carcinoma: prognostic factors.
Topics: Adult; Aged; Bile Duct Neoplasms; Cholangiocarcinoma; Embolization, Therapeutic; Female; Humans; Male; Microspheres; Middle Aged; Positron-Emission Tomography; Prognosis; Retrospective Studies; Tomography, X-Ray Computed; Young Adult; Yttrium Radioisotopes | 2016 |
Yttrium-90 radioembolization for unresectable/recurrent intrahepatic cholangiocarcinoma: a survival, efficacy and safety study.
Topics: Adult; Aged; Aged, 80 and over; Bile Duct Neoplasms; Cholangiocarcinoma; Embolization, Therapeutic; Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Survival Analysis; Yttrium Radioisotopes | 2016 |
Comparison of Choi criteria and Response Evaluation Criteria in Solid Tumors (RECIST) for intrahepatic cholangiocarcinoma treated with glass-microspheres Yttrium-90 selective internal radiation therapy (SIRT).
Topics: Adult; Aged; Aged, 80 and over; Bile Duct Neoplasms; Brachytherapy; Cholangiocarcinoma; Female; Humans; Male; Microspheres; Middle Aged; Response Evaluation Criteria in Solid Tumors; Retrospective Studies; Survival Analysis; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2016 |
Multimodal Therapy including Yttrium-90 Radioembolization as a Bridging Therapy to Liver Transplantation for a Huge and Locally Advanced Intrahepatic Cholangiocarcinoma.
Topics: Adult; Bile Duct Neoplasms; Chemoradiotherapy, Adjuvant; Cholangiocarcinoma; Embolization, Therapeutic; Humans; Liver Transplantation; Male; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Staging; Radiopharmaceuticals; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden; Yttrium Radioisotopes | 2016 |
Radiation lobectomy: preliminary findings of hepatic volumetric response to lobar yttrium-90 radioembolization.
Topics: Adult; Aged; Aged, 80 and over; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hepatocellular; Cholangiocarcinoma; Embolization, Therapeutic; Female; Humans; Liver; Liver Neoplasms; Male; Microspheres; Middle Aged; Organ Size; Yttrium Radioisotopes | 2009 |
Yttrium-90 radiotherapy for unresectable intrahepatic cholangiocarcinoma: a preliminary assessment of this novel treatment option.
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Embolization, Therapeutic; Female; Follow-Up Studies; Humans; Male; Microspheres; Middle Aged; Prospective Studies; Survival Rate; Treatment Outcome; Yttrium Radioisotopes | 2010 |
18F-FDG PET independently predicts survival in patients with cholangiocellular carcinoma treated with 90Y microspheres.
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Embolization, Therapeutic; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Liver Neoplasms; Male; Microspheres; Middle Aged; Positron-Emission Tomography; Prognosis; Retrospective Studies; Serum Albumin; Survival Analysis; Technetium Tc 99m Aggregated Albumin; Tin Compounds; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2011 |
Transarterial hepatic yttrium-90 radioembolization in patients with unresectable intrahepatic cholangiocarcinoma: factors associated with prolonged survival.
Topics: Aged; Aged, 80 and over; Angiography; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Biomarkers, Tumor; CA-19-9 Antigen; Cholangiocarcinoma; Disease Progression; Embolization, Therapeutic; Female; Fluoroscopy; Humans; Liver Function Tests; Liver Neoplasms; Magnetic Resonance Imaging; Male; Microspheres; Middle Aged; Retrospective Studies; Survival Rate; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2012 |
Yttrium-90 radioembolization for unresectable standard-chemorefractory intrahepatic cholangiocarcinoma: survival, efficacy, and safety study.
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Chi-Square Distribution; Cholangiocarcinoma; Female; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Prospective Studies; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2013 |
Radiation exposure during liver surgery after treatment with (90)Y microspheres, evaluated with computer simulations and dosimeter measurements.
Topics: Adult; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Computer Simulation; Female; Fingers; General Surgery; Humans; Liver Neoplasms; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiation Dosage; Radiometry; Radiotherapy Dosage; Tomography, X-Ray Computed; Yttrium Radioisotopes | 2012 |
Prognostic factors and prevention of radioembolization-induced liver disease.
Topics: Aged; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Brachytherapy; Carcinoma, Hepatocellular; Cholangiocarcinoma; Cohort Studies; Embolization, Therapeutic; Female; Follow-Up Studies; Humans; Incidence; Jaundice; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Prognosis; Radiation Injuries; Severity of Illness Index; Yttrium Radioisotopes | 2013 |
Extended right trisegmentectomy using in situ hypothermic perfusion with modified HTK solution for a large intrahepatic cholangiocarcinoma.
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Biliary Tract Surgical Procedures; Cholangiocarcinoma; Cisplatin; Combined Modality Therapy; Doxorubicin; Female; Glucose; Hepatectomy; Humans; Hypothermia, Induced; Immunoglobulin G; Jejunostomy; Mannitol; Melphalan; Middle Aged; Perfusion; Potassium Chloride; Procaine; Tomography, Spiral Computed; Yttrium Radioisotopes | 2007 |